| Title： | Chinese Expert Consensus on Transcutaneous Spinal Cord Stimulation for Painful Diabetic Neuropathy |
| Edition： | Original |
| Classification： | Experts consensus |
| Field： | Diagnosis and Treatment |
| Countries and regions： | China |
| Guidelines users： | This Consensus is intended for clinical doctors involved in the treatment of painful diabetic neuropathy (PDN) with spinal cord stimulation (SCS), including those in the departments of pain management, endocrinology, neurosurgery, neurology, and general practice. |
| Evidence classification method： | High (A) - Further research is unlikely to change the confidence in the efficacy assessment results. Moderate (B) - Further research is likely to affect the confidence in the efficacy assessment results and may change the assessment results. Low (C) - Further research is very likely to affect the confidence in the efficacy assessment results, and the assessment results are likely to change. Very Low (D) - Any efficacy assessment results are very uncertain. Strong Recommendation (1) - Unanimous agreement (supporting opinions ≥80%). Weak Recommendation (2) - Basic consensus with minor disagreements (supporting opinions 60% to 80%). No Consensus (3) - No consensus with significant disagreements (supporting opinions <60%). |
| Development unit： | Chinese Neuromodulation Society；School of Medicine, the First Affiliated Hospital, Zhejiang University |
| Registration time: | 2024-06-09 |
| Registration number： | PREPARE-2024CN773 |
| Purpose of the guideline: | To promote the standardization and regularization of Spinal Cord Stimulation (SCS) techniques, the Chinese Neuromodulation Society, in collaboration with experienced domestic and international experts, has formulated the "Chinese Expert Consensus on Spinal Cord Stimulation for Painful Diabetic Neuropathy (2024)". This Consensus is based on existing literature evidence and the clinical practice in China, aiming to ensure clinical efficacy while minimizing the occurrence of adverse reactions. |
